|
SYNTHES GMBH 3.5MM TI LOCKING SCR SLF-TPNG WITH STARDRIVE RECESS 20MM; APPLIANCE, FIXATION, NAIL/BLADE/PLATE COMBINATION, MULTIPLE COMPONENT
|
Back to Search Results |
|
| Catalog Number |
412.106TS |
| Medical Device Problem Code |
Break (1069)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
03/06/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Device report from synthes reports an event in japan as follows: it was reported that on (b)(6) 2023, the patient underwent an osteosynthesis for a supracondylar fracture of the femur.In the surgery, an lcp-df plate was implanted on the lateral side and the lcp one-third tubular plate was implanted on the medial side.After the surgery, the screw for the lcp one-third tubular plate broke off.On (b)(6) 2024, a revision surgery was performed.There were no problems with the other screws that came out.The revision surgery was completed successfully with no surgical delay.The surgeon has judged that the revision was unavoidable because of the micromotion that would have occurred.The surgeon commented that a large standard plate should have been used for medial fixation as well.The patient status/ outcome reported as stable no further information is available.This report is for one (1) lockscr ø3.5 self-tap l20 tan.This is report 3 of 3 for complaint(b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.D9: complainant part is expected to be returned for manufacturer review/investigation but has yet to be received.E3: reporter is a j&j sales representative.H3, h4, h6: without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
H4: manufacture date added.D4: lot number and expiration date added.Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.D10: date of concomitant therapy is (b)(6) 2023.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H11.Additional narrative: a manufacturing record evaluation was performed for the finished device product code: 412.106ts, lot number: 1623p26, it was electronically reviewed and no nonconformances / manufacturing irregularities were identified during the manufacturing process.The product was released on: 15-sep-2022, manufacturing site: jabil grenchen, expiry date: 01-sep-2027.Product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.H6 component code: g07002 (appropriate term/code not available) used to capture no findings available due to no product returned.Corrected data: g1: manufacturing site name and address.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Search Alerts/Recalls
|
|
|